Biological Control of Rice Diseases (e-bog) af Gnanamanickam, Samuel S.

Biological Control of Rice Diseases e-bog

1240,73 DKK (inkl. moms 1550,91 DKK)
There is suf?cient need to document all the available data on biological control of rice diseases in a small volume. Part of this need rests on the global importance of rice to human life. In the ?rst chapter, I have tried to show that rice is indeed life for most people in Asia and shortages in production and availability can lead to a food crisis. While rice is cultivated in most continents, ...
E-bog 1240,73 DKK
Forfattere Gnanamanickam, Samuel S. (forfatter)
Forlag Springer
Udgivet 14 juli 2009
Genrer Microbiology (non-medical)
Sprog English
Format pdf
Beskyttelse LCP
ISBN 9789048124657
There is suf?cient need to document all the available data on biological control of rice diseases in a small volume. Part of this need rests on the global importance of rice to human life. In the ?rst chapter, I have tried to show that rice is indeed life for most people in Asia and shortages in production and availability can lead to a food crisis. While rice is cultivated in most continents, biological disease management attains special relevance to rice farmers of Africa, Asia, and also perhaps, Latin America. These farmers are resource-poor and might not be able to afford the cost of expensive chemical treatments to control devastating rice pathogens such as Magnaporthe oryzae (blast), Xanthomonas oryzae pv. oryzae (bacterial leaf blight), Rhizoctonia solani (sheath blight) and the virus, rice tungro disease. In an earlier volume that I developed under the title, Biological Control of Crop Diseases (Dekker/CRC Publishers, 2002), I included transgenic crops generated for the management of plant pathogens as biological control under the umbrella of a broad de?nition. Dr Jim Cook who wrote the Foreword for the volume lauded the inclusion of transgenic crops and induced systemic resistance (ISR) as a positive trend toward acceptance of host plant resistance as part of biocontrol. I continue to subscribe to this view.